Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. (Q40601643)
Jump to navigation
Jump to search
scientific article published on June 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. |
scientific article published on June 2001 |
Statements
Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season (English)
Wilson DR
Nouri-Aria KT
Pajno GB
O'Brien F
Mackay IS